04/06/2026
We want to take a moment to recognize an achievement that exemplifies what Velocity at Scale is all about.
Kirsten Peacey, MBBS and her team at our Bristol, UK site have reached a major Phase 3 trial milestone — completing End of Screening 4.5 months ahead of the original projected timeline.
That's not luck. It's what happens when an experienced, protocol-ready team operates within a purpose-built research network.
Dr. Peacey's site was the top-performing UK site on this study — leading on randomizations, maintaining strong screen failure rates, and upholding the highest standards of patient safety and data quality throughout.
This is precisely why Velocity invests in building sites that are consistently ready to perform:
• Faster activation — dedicated infrastructure means our sites are trial-ready from day one, not months later
• Reduced risk — experienced teams with proven protocols deliver consistent, high-quality results sponsors can rely on
• Velocity at Scale — when operational excellence is shared across our network, every site benefits — and so do our sponsors
To Dr. Peacey and the entire Bristol team: thank you. Your dedication brought a potential new therapy closer to the patients who need it — ahead of schedule and without compromise.